Skip to content
March 20, 2023


Investment information for the new generation

XPhyto Therapeutics (XPHY.C) Signs Acquisition Deal with 3a-Diagnostics, Enters Biosensor Market

XPhyto Therapeutics (XPHY.C) announced today that it has signed a definitive agreement for the acquisition of 3a-Diagnostics GmhB, Frickenhausen, Germany, XPhyto’s exclusive diagnostic development partner. Read full article here:

Related Posts

More on